rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

James F. Oliviero III

Director

Company insider

Files Form 4 as: Director, Nuvectis Pharma; CEO, President and Director, Checkpoint Therapeutics; Chief Financial Officer, Keryx Biopharmaceuticals.

Every Form 4 they filed

In numbers

Trades disclosed
117
Buys
2
Sells
59
Bought
$12K
Sold
$15.2M
Companies
3
Companies where not an officer
1
First trade
14 Aug 2008
Last trade
11 Jun 2026
Last filed
12 Jun 2026

Companies traded

Where they are an officer
Checkpoint TherapeuticsDirector, Officer · last 30 May 20250 buys · 21 sells
Keryx BiopharmaceuticalsOfficer · last 6 Jul 20152 buys · 38 sells
Everywhere else they filed: board seats, 10% stakes, other companies
NVCT Nuvectis PharmaDirector · Biotechnology · last 11 Jun 20260 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
20Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
11 Jun 2026filed 12 Jun 2026NVCT Nuvectis PharmaBiotechnologySEC FORM 4 Code A—35,000 at $0.00filing
11 Jun 2026filed 12 Jun 2026NVCT Nuvectis PharmaBiotechnologySEC FORM 4 Code A—35,000 at $0.00filing
12 Jun 2025filed 12 Jun 2025NVCT Nuvectis PharmaBiotechnologySEC FORM 4 Code A—30,000 at $0.00filing
30 May 2025filed 30 May 2025Checkpoint TherapeuticsSEC FORM 4 Code U—3,759,929filing
2 Apr 2025filed 3 Apr 2025Checkpoint TherapeuticsSEC FORM 4 Sold$61K15,090 at $4.04filing
10 Feb 2025filed 11 Feb 2025Checkpoint TherapeuticsSEC FORM 4 Sold$33K10,331 at $3.15filing
7 Feb 2025filed 11 Feb 2025Checkpoint TherapeuticsSEC FORM 4 Sold$31K9,233 at $3.41filing
30 Jan 2025filed 31 Jan 2025Checkpoint TherapeuticsSEC FORM 4 Code A—1,500,000 at $0.00filing
20 Dec 2024filed 20 Dec 2024Checkpoint TherapeuticsSEC FORM 4 Code G—900,000 at $0.00filing
19 Dec 2024filed 20 Dec 2024Checkpoint TherapeuticsSEC FORM 4 Sold$744K220,230 at $3.38filing
18 Dec 2024filed 20 Dec 2024Checkpoint TherapeuticsSEC FORM 4 Sold$2.3M602,167 at $3.87filing
13 Dec 2024filed 17 Dec 2024Checkpoint TherapeuticsSEC FORM 4 Code A—2,077,700 at $0.00filing
26 Jun 2024filed 28 Jun 2024Checkpoint TherapeuticsSEC FORM 4 Sold$50K24,610 at $2.05filing
26 Jun 2024filed 28 Jun 2024Checkpoint TherapeuticsSEC FORM 4 Code G—37,890 at $0.00filing
13 Jun 2024filed 13 Jun 2024NVCT Nuvectis PharmaBiotechnologySEC FORM 4 Code A—30,000 at $0.00filing
24 May 2024filed 24 May 2024Checkpoint TherapeuticsSEC FORM 4 Code A—1,660,000 at $0.00filing
28 Feb 2024filed 1 Mar 2024Checkpoint TherapeuticsSEC FORM 4 Sold$12K5,894 at $2.06filing
28 Feb 2024filed 1 Mar 2024Checkpoint TherapeuticsSEC FORM 4 Code G—9,056 at $0.00filing
1 Feb 2024filed 2 Feb 2024Checkpoint TherapeuticsSEC FORM 4 Sold$24K11,900 at $2.01filing
1 Feb 2024filed 2 Feb 2024Checkpoint TherapeuticsSEC FORM 4 Code G—12,950 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Not placed61

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.